Sep 1, 2026 · 36 min · 11 segments
**Opinion:** https://www.supremecourt.gov/opinions/25pdf/24-1068\_n7ip.pdf ## Case background Monsanto Company manufactures and…
Monsanto Company manufactures and distributes Roundup, a glyphosate-based herbicide designed to control weeds.
The Environmental Protection Agency has repeatedly evaluated glyphosate, and repeatedly concluded that it is not likely to cause cancer, and so has never required a cancer warning on the labels of glyphosate-based pesticides like Roundup.
He brought a failure-to-warn tort claim, asserting that Monsanto should have included a cancer warning on Roundup's label.
A jury agreed and awarded Durnell more than $1 million, and the Missouri Court of Appeals affirmed, rejecting Monsanto's argument that the Federal Insecticide, Fungicide, and Rodenticide Act expressly preempted the claim.
The question presented was whether the Federal Insecticide, Fungicide, and Rodenticide Act preempts a state law failure to warn claim where the Environmental Protection Agency has repeatedly concluded that the warning is not required and the warning cannot be added to a product without that agency's approval.
The court held the Federal Insecticide, Fungicide, and Rodenticide Act expressly preempts Durnell's state law failure to warn claim, because the claim would require Monsanto to add a cancer warning to Roundup's label.
The Act's preemption clause, entitled Uniformity, bars a state from imposing any labeling requirement in addition to or different from those required under federal law.
To register a pesticide, the Environmental Protection Agency must approve its label by determining that the label carries all warnings necessary and adequate to protect health and the environment and contains no false or misleading statements.
and once that label is approved, a manufacturer is legally required to use it unless and until the agency approves or requires a change.
State tort duties constitute state labeling requirements, so Durnell's claim, which would compel a cancer warning the agency has not required, is in addition to and different from Monsanto's federal law labeling obligations.
The court's decision in Regal v. Medtronic, addressing the materially identical preemption clause of the medical device amendments, confirms that conclusion.
Justice Thomas filed a concurring opinion.
Monsanto Company manufactures and distributes Roundup, a glyphosate-based herbicide designed to control weeds.
The Environmental Protection Agency has repeatedly evaluated glyphosate, and repeatedly concluded that it is not likely to cause cancer, and so has never required a cancer warning on the labels of glyphosate-based pesticides like Roundup.
He brought a failure-to-warn tort claim, asserting that Monsanto should have included a cancer warning on Roundup's label.
A jury agreed and awarded Durnell more than $1 million, and the Missouri Court of Appeals affirmed, rejecting Monsanto's argument that the Federal Insecticide, Fungicide, and Rodenticide Act expressly preempted the claim.
The question presented was whether the Federal Insecticide, Fungicide, and Rodenticide Act preempts a state law failure to warn claim where the Environmental Protection Agency has repeatedly concluded that the warning is not required and the warning cannot be added to a product without that agency's approval.
The court held the Federal Insecticide, Fungicide, and Rodenticide Act expressly preempts Durnell's state law failure to warn claim, because the claim would require Monsanto to add a cancer warning to Roundup's label.
The Act's preemption clause, entitled Uniformity, bars a state from imposing any labeling requirement in addition to or different from those required under federal law.
To register a pesticide, the Environmental Protection Agency must approve its label by determining that the label carries all warnings necessary and adequate to protect health and the environment and contains no false or misleading statements.
and once that label is approved, a manufacturer is legally required to use it unless and until the agency approves or requires a change.
State tort duties constitute state labeling requirements, so Durnell's claim, which would compel a cancer warning the agency has not required, is in addition to and different from Monsanto's federal law labeling obligations.
The court's decision in Regal v. Medtronic, addressing the materially identical preemption clause of the medical device amendments, confirms that conclusion.
Justice Thomas filed a concurring opinion.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.